SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-051922
Filing Date
2020-04-28
Accepted
2020-04-28 06:53:01
Documents
16
Period of Report
2020-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016917d1_8k.htm   iXBRL 8-K 36368
2 EXHIBIT 99.1 tm2016917d1_ex99-1.htm EX-99.1 366679
3 EXHIBIT 99.2 tm2016917d1_ex99-2.htm EX-99.2 308567
8 GRAPHIC tm2016917d1_ex99-1img001.jpg GRAPHIC 13229
  Complete submission text file 0001104659-20-051922.txt   1022577

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20200428.xsd EX-101.SCH 4497
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20200428_def.xml EX-101.DEF 28711
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20200428_lab.xml EX-101.LAB 39013
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20200428_pre.xml EX-101.PRE 27320
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2016917d1_8k_htm.xml XML 8774
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 20822213
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences